DE3762969D1 - Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. - Google Patents
Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.Info
- Publication number
- DE3762969D1 DE3762969D1 DE8787108991T DE3762969T DE3762969D1 DE 3762969 D1 DE3762969 D1 DE 3762969D1 DE 8787108991 T DE8787108991 T DE 8787108991T DE 3762969 T DE3762969 T DE 3762969T DE 3762969 D1 DE3762969 D1 DE 3762969D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical composition
- piperazine compounds
- production
- phophylaxis
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61147789A JPS632986A (ja) | 1986-06-23 | 1986-06-23 | 新規なピペラジン誘導体および該化合物を有効成分とする抗潰瘍薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3762969D1 true DE3762969D1 (de) | 1990-07-05 |
Family
ID=15438237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787108991T Expired - Fee Related DE3762969D1 (de) | 1986-06-23 | 1987-06-23 | Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4797400A (de) |
EP (1) | EP0251141B1 (de) |
JP (1) | JPS632986A (de) |
AT (1) | ATE53209T1 (de) |
DE (1) | DE3762969D1 (de) |
ES (1) | ES2016305B3 (de) |
GR (1) | GR3000831T3 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9904045D0 (sv) * | 1999-11-09 | 1999-11-09 | Astra Ab | Compounds |
US9018288B2 (en) | 2007-08-02 | 2015-04-28 | Lubrizol Advanced Materials, Inc. | Thermoplastic composition |
US8524818B2 (en) | 2008-01-18 | 2013-09-03 | Lubrizol Advanced Materials, Inc. | Thermoplastic composition |
CN102575112B (zh) | 2009-07-07 | 2014-04-30 | 路博润高级材料公司 | 热塑性组合物 |
IL308744A (en) | 2017-06-20 | 2024-01-01 | Imbria Pharmaceuticals Inc | Preparations for use to increase the efficiency of heart metabolism |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2996506A (en) * | 1961-08-15 | Hcxchb | ||
US2907764A (en) * | 1956-07-30 | 1959-10-06 | Searle & Co | Heterocyclic esters of 3, 4, 5-trimethoxybenzoic acid |
US3025297A (en) * | 1959-12-01 | 1962-03-13 | Searle & Co | Aminoalkyl esters of 3, 4, 5-trihalobenzoic acids |
GB1102011A (en) * | 1964-05-21 | 1968-02-07 | Richardson Merrell Spa | Phenol esters of amino acids |
GB1139934A (en) * | 1966-08-18 | 1969-01-15 | Delalande Sa | Cinnamylpiperazine preparations |
DE1670478A1 (de) * | 1967-10-12 | 1971-02-11 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von Derivaten des alpha-Piperazino-phenylacetonitrils |
AT284130B (de) * | 1967-12-06 | 1970-09-10 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung von neuen, am Kohlenstoff des Heterocyclus alkylierten N,N'-disubstituierten Diazacycloalkanen und deren Säueeadditionssalzen |
GB1186495A (en) * | 1968-02-20 | 1970-04-02 | Delalande Sa | 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation |
FR2092630B1 (de) * | 1970-06-03 | 1974-03-22 | Delalande Sa | |
GB1452413A (de) * | 1973-08-16 | 1976-10-13 | Fuji Chem Ind Co Ltd | |
US4397855A (en) * | 1981-06-26 | 1983-08-09 | Warner-Lambert Company | 4-(Substituted)-α, α-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method |
JPS6113771A (ja) * | 1984-06-28 | 1986-01-22 | Saiteku Kk | Plztを用いたラインスキヤナ− |
-
1986
- 1986-06-23 JP JP61147789A patent/JPS632986A/ja active Granted
-
1987
- 1987-06-16 US US07/062,573 patent/US4797400A/en not_active Expired - Fee Related
- 1987-06-23 DE DE8787108991T patent/DE3762969D1/de not_active Expired - Fee Related
- 1987-06-23 EP EP87108991A patent/EP0251141B1/de not_active Expired - Lifetime
- 1987-06-23 ES ES87108991T patent/ES2016305B3/es not_active Expired - Lifetime
- 1987-06-23 AT AT87108991T patent/ATE53209T1/de not_active IP Right Cessation
-
1990
- 1990-08-20 GR GR90400162T patent/GR3000831T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0251141A1 (de) | 1988-01-07 |
EP0251141B1 (de) | 1990-05-30 |
US4797400A (en) | 1989-01-10 |
ATE53209T1 (de) | 1990-06-15 |
JPH0533952B2 (de) | 1993-05-20 |
GR3000831T3 (en) | 1991-11-15 |
ES2016305B3 (es) | 1990-11-01 |
JPS632986A (ja) | 1988-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9200857D0 (en) | Process for the production of new tiophenecarbonic acid esthers of amino-alcoholes, their quaterner derivatives and of medical preparations containing them as active agents | |
ATE51231T1 (de) | Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel. | |
ATE37882T1 (de) | Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
ATE135577T1 (de) | Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht | |
ATE131173T1 (de) | Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus. | |
GR3020098T3 (en) | 11-Beta-aryl-4-estrene, method for its production and its use as a medicine | |
ATE111912T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate. | |
AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
ATE201024T1 (de) | Carbamatderivate von 4-amino-3-isoxazolidinonen und 3-amino-1-hydroxypyrrolidinon-2-onen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE3762969D1 (de) | Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. | |
DE3769563D1 (de) | Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung. | |
EP0086416A3 (de) | Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE21101T1 (de) | N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel. | |
ATE38982T1 (de) | Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel. | |
ATE44950T1 (de) | Polyprenylverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE55250T1 (de) | Ifosfamid-lyophilisat und verfahren zu dessen herstellung. | |
ATE41659T1 (de) | Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen. | |
DE3781879D1 (de) | Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
IE873212L (en) | Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor | |
DE3886185D1 (de) | 2-Thiazolidinon-Derivate und diese enthaltende pharmazeutische Präparate, Verfahren zu deren Herstellung und deren Verwendung. | |
ATE168692T1 (de) | 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE3767533D1 (de) | D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung. | |
DE3674250D1 (de) | Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung. | |
ATA39088A (de) | Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung | |
ATE40687T1 (de) | Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |